(Q39765196)

English

AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

J G Boyle

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

P J Logan

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

G C Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

M Small

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

N Sattar

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

J M C Connell

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S J Cleland

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

I P Salt

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1799-1809

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

AMPK: a key regulator of energy balance in the single cell and the whole organism.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

AMPK: an emerging drug target for diabetes and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

The effects of AICAR on adipocyte differentiation of 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Effect of gliclazide modified release on adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Inhibition of tumor necrosis factor alpha-stimulated monocyte adhesion to human aortic endothelial cells by AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2126-4

21 January 2018

Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21455728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and role of the basal phosphorylation site on hormone-sensitive lipase

1 reference

https://pubmed.ncbi.nlm.nih.gov/21455728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of AMP-activated protein kinase in fat depot-specific metabolic changes during starvation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21455728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-011-2126-4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39765196&oldid=2203160360"